{{Rsnum
|rsid=12592967
|Chromosome=15
|position=61578744
|Orientation=plus
|GMAF=0.4036
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 21.4 | 46.4 | 32.1
| HCB | 51.8 | 40.9 | 7.3
| JPT | 32.7 | 48.7 | 18.6
| YRI | 71.4 | 26.5 | 2.0
| ASW | 47.4 | 49.1 | 3.5
| CHB | 51.8 | 40.9 | 7.3
| CHD | 56.9 | 35.8 | 7.3
| GIH | 27.7 | 47.5 | 24.8
| LWK | 70.0 | 27.3 | 2.7
| MEX | 25.9 | 51.7 | 22.4
| MKK | 37.8 | 49.4 | 12.8
| TSI | 19.6 | 45.1 | 35.3
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22688191
|Trait=None
|Title=Genome-wide association study in a Swedish population yields support for greater CNV and MHC involvement in schizophrenia compared with bipolar disorder.
|RiskAllele=
|Pval=3E-7
|OR=1.1000
|ORtxt=None
|OA=1
}}

{{on chip | Affy GenomeWide 6}}